(Q33807755)

English

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dimosthenis Miliaras

object named as

Dimosthenis Miliaras

9

0 references

Athanasios Dimopoulos

object named as

Meletios A Dimopoulos

5

0 references

George Fountzilas

26

object named as

George Fountzilas

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Christos Efstratiou

0 references

Dimitrios Bafaloukos

13

object named as

Dimitrios Bafaloukos

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimitrios Pectasides

16

object named as

Dimitrios Pectasides

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Epaminontas Samantas

7

object named as

Epaminontas Samantas

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Pavlos Papakostas

2

object named as

Pavlos Papakostas

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Theofanis Economopoulos

18

object named as

Theofanis Economopoulos

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

object named as

Nikolaos Xiros

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Gerasimos Aravantinos

24

object named as

Gerasimos Aravantinos

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Aristotelis Bamias

8

object named as

Aristotelis Bamias

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Thomas Makatsoris

22

object named as

Thomas Makatsoris

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

object named as

Lia Malettou

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

George Pentheroudakis

6

object named as

George Pentheroudakis

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

12

object named as

George Klouvas

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Charisios Karanikiotis

17

object named as

Charisios Karanikiotis

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ioannis Efstratiou

19

object named as

Ioannis Efstratiou

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ippokratis Korantzis

20

object named as

Ippokratis Korantzis

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nikolaos Pisanidis

21

object named as

Nikolaos Pisanidis

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

25

object named as

Haralabos P Kalofonos

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Christos A Papadimitriou

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Maria Karina

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

George Basdanis

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Georgia Kafiri

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Irene Papaspirou

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Fotini Matsiakou

23

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

31 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Current status of adjuvant therapy for colon cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Adjuvant therapy in colon cancer--what, when and how?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

The camptothecins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

4 July 2018

Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-10

21 January 2018

Oxaliplatin or irinotecan as adjuvant therapy for colon cancer: the results are in.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-10

21 January 2018

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-10

21 January 2018

A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-10

21 January 2018

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-10

21 January 2018

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-10

21 January 2018

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-10

21 January 2018

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-10

21 January 2018

Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the Hellenic Cooperative Oncology Group (HeCOG).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038965

30 October 2018

Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21281463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21281463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21281463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803

1 reference

https://pubmed.ncbi.nlm.nih.gov/21281463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic treatment of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21281463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1741-7015-9-10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33807755&oldid=2195813267"